For citations:
Kovalenko E.I., Artamonova E.V., Zhulikov Ya.A., Khoroshilov M.V. Neoadjuvant chemotherapy for HER2-positive breast cancer using dose-consolidated regimens and dual anti-HER2 blockade with pertuzumab and trastuzumab (preliminary results). Medical alphabet. 2021;1(31):38-43. (In Russ.) https://doi.org/10.33667/2078-5631-2021-31-38-43
Email this article 